Back

Automated screening tool for Subcutaneous Implantable Defibrillator in Brugada syndrome has a high eligibility rate which is predicted by simple electrocardiographic parameters

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Outcomes with Cardiac Implanted Electronic Devices and Their Follow-Up Implantable Cardioverter-Defibrillator (ICD) ESC Premium Access ESC Congress 2020

About the speaker

Photo
Mr Stefano Marelli

ICS Maugeri - IRCCS Pavia, Pavia (Italy)

7 More presentations in this session

Presentation thumbnail
Long-term follow-up of patients with tetralogy of Fallot and implantable cardioverter defibrillator
Doctor V. Waldmann (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Change in QRS area by cardiac resynchronization therapy is associated with clinical outcomes and echocardiographic response
Mr M. Ghossein (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Risk factors for mortality within one-year after implantable cardioverter defibrillator implantation: a nationwide study
Miss A. Alhakak (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Relationship between mortality after ICD implantation and center volume in Belgium
Mr R. Hoffmann (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Mortality after implantable cardioverter defibrillators in dialysis patients: a nationwide study
Miss A. Alhakak (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Outcomes with Cardiac Implanted Electronic Devices and Their Follow-Up

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Session
Debate on primary prevention in ICD therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources